Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Central Excise Central Excise + AT Central Excise - 2011 (3) TMI AT This

  • Login
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2011 (3) TMI 1215 - AT - Central Excise


Issues involved: Classification of 'Vicks Cough Drop' under CHS no. 3003.10 as P&P Medicaments or under CHS no. 3003.39 as Ayurvedic medicaments.

Analysis:
- The appellants challenged the classification of 'Vicks Cough Drop' by the lower authorities as P&P Medicaments under CHS no. 3003.10.
- Despite the absence of the appellants during the hearing, the appeal was considered on merits.
- The central issue in the case was whether 'Vicks Cough Drop' should be classified as Ayurvedic medicaments under Chapter heading 3003.39 or as P&P medicaments under Chapter heading 3003.10.
- The Tribunal referred to a previous judgment by the Hon'ble Apex Court in the case of Neutrela Health Products vs. CCE 2003, where it was established that Vicks are ayurvedic medicaments classifiable under heading 3003.39.
- The Tribunal also cited its own previous decision in the appellants' case, where it followed the Neutrela judgment and classified Vicks as ayurvedic medicaments under heading 3003.39.
- Based on the precedents and legal interpretation, the Tribunal concluded that 'Vicks Cough Drop' should be classified as ayurvedic medicaments under chapter heading 3003.39.
- Consequently, the impugned order classifying 'Vicks Cough Drop' as P&P medicaments under chapter heading 3003.10 was set aside, and the appeal was allowed with consequential relief.

 

 

 

 

Quick Updates:Latest Updates